Why the study?
Do equipotent doses of different calcium channel blockers produce similar central hemodynamic effects in healthy individuals?
Do equipotent doses of different calcium channel blockers produce similar central hemodynamic effects in healthy individuals?
Different calcium channel blockers produce similar central hemodynamic effects in healthy individuals when administered at equipotent doses, despite differing in vitro profiles.
Answers are grounded in this paper and cite their sources.
Supports equipotent CCB dosing for central hemodynamics in healthy subjects; leaves open effects in cardiovascular disease.
Despite differences in vasodilatation, inotropy and chronotropy between verapamil, nifedipine and diltiazem when tested in vitro, these drugs will produce similar central hemodynamic effects in healthy young or middle-aged individuals, provided they are given in equipotent doses. The individual profiles of hemodynamic action of these calcium channel blockers are briefly reviewed and discussed.
No takes yet. Share an insight, caveat, or question.
Lars‐Göran Ekelund (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: